tetraethylammonium has been researched along with Anisocoria in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Anisocoria: Unequal pupil size, which may represent a benign physiologic variant or a manifestation of disease. Pathologic anisocoria reflects an abnormality in the musculature of the iris (IRIS DISEASES) or in the parasympathetic or sympathetic pathways that innervate the pupil. Physiologic anisocoria refers to an asymmetry of pupil diameter, usually less than 2mm, that is not associated with disease.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
OKINAKA, S | 1 |
NAKAMURA, H | 1 |
TSUBAKI, T | 1 |
KUROIWA, Y | 1 |
TOYOKURA, Y | 1 |
1 other study available for tetraethylammonium and Anisocoria
Article | Year |
---|---|
A contribution to the study of pathogenesis of the pupillary changes in severe cerebral apoplexy and in chronic hemiplegia. A. Clinico-pathological studies on anisocoria in severe apoplexy attack. B. Clinico-pathological studies on anisocoria in chronic h
Topics: Animals; Anisocoria; Behavior, Animal; Cerebral Hemorrhage; Hemiplegia; Humans; Pupil; Pupil Disorde | 1953 |